Tackling the most important problems in cancer research through innovative thinking and a multidisciplinary approach
Building on 45 years of excellence in cancer research and training
Affiliated with McGill University’s Faculty of Medicine and Health Sciences, the Rosalind & Morris Goodman Cancer Institute brings together world-leading scientists and clinicians in a vibrant, collaborative environment.
Together we are tackling the most important problems in cancer research through innovative thinking and a multidisciplinary approach, supported by top-notch infrastructures and a dedicated staff of research and administrative professionals.
As we reflect on the growth and development of our Institute, we see how the many outstanding discoveries of our researchers have shaped modern cancer research at McGill and around the world. From the first cancer biomarker to unlocking the therapeutic potential of RNA, our legacy of ground-breaking research is both a source of pride and the foundation of our current programs.
Professor John Stagg
Director, Rosalind and Morris Goodman Cancer Institute
Professor, Deptartment of Microbiology and Immunology, McGill University
We strive to understand what drives cancer in order to better prevent, diagnose and treat the disease
This is how we do it…
Accelerating discoveries in cancer research
Generating new knowledge and working with partners to give cancer patients new opportunities.
Leading through collaboration
Collaboration is deeply engraved in our DNA. We believe in bringing together the best minds across various disciplines to tackle cancer faster and more effectively.
Ensuring a sustainable future for cancer research
We are dedicated to imparting our knowledge by training the next generation of cancer research leaders to the benefit of the entire scientific community and to helping position Quebec as a top cancer research hub.
FRQ-S Research Axes
______________________
Understanding how normal cells and tissues transition to pre-malignancy and then early-stage cancers.
Axis lead: Peter Siegel
______________________
Identifying targetable vulnerabilities in tumour cells and exploiting these discoveries to empower precision medicine.
Axis lead: Ian Watson
______________________
A holistic approach to understanding cancer as a systemic disease by deciphering networks of tumour-host interactions.
Axis lead: Daniela Quail
______________________
Building on recent innovations in RNA therapies and vaccines, this effort aims to design RNA-based genomic medicines for cancer.
Axis lead: Thomas Duchaine
Our research themes
Home to the best
minds in cancer
research
Our world-leading experts from various disciplines such as cancer biology, clinical oncology, computer science, mathematics, engineering, and physics come together to devise innovative solutions to such a complex disease.
Strong leadership leads to great science
Our forward-looking leadership team is made up of dedicated and experienced scientists who, through their vision, proven expertise, and unyielding commitment, help us push the boundaries of our research.
Excellence rooted in the legacy of our pioneers
Our Institute is home to some of the world's leading scientists in the field of cancer research. Their legacy continues to uphold and inspire our team's endeavors to make cancer a disease of the past.
Rosalind & Morris Goodman Cancer Institute all rights reserved • Privacy policy • Accessibility
Website by Riposte
